Products & Technology

 
Precision Biomarker Analysis
Enabling New Insights into the
Biology of Health and Disease

The company’s digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, Quanterix enables development of methods to provide much earlier disease detection, better prognoses and enhanced treatment methods and improve the quality of life and longevity of the population for generations to come. The technology is currently being used for applications in a majority of therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. 

Simoa by the Numbers

Number of Scientific Publications
Number of Simoa Assays
Average Simoa LoD (fg/mL)
Average Simoa LoQ (fg/mL)

Latest News

04.19
Tauopathies are a group of disorders in which the cytosolic protein tau aggregates and accumulates…
04.18
Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines have been…
04.17
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated…
04.14
The results from these 2 independent cohort studies suggest that serum NFL is a highly sensitive…